Incidence, Predictors, and Prognostic Impact of Immediate Improvement in Left Ventricular Systolic Function After Transcatheter Aortic Valve Implantation

Am J Cardiol. 2021 Aug 1:152:99-105. doi: 10.1016/j.amjcard.2021.04.037. Epub 2021 Jun 11.

Abstract

Immediate improvement in left ventricular ejection fraction (LVEF) following transcatheter aortic valve implantation (TAVI) is common; however, data on the pattern and prognostic value of this improvement are limited. To evaluate the incidence, predictors, and clinical impact of immediate improvement in LVEF, we studied 694 consecutive patient who had underwent successful TAVI for severe aortic stenosis (AS) between March 2010 and December 2019. We defined immediate improvement of LVEF as an absolute increase of ≥5% in LVEF at post-procedure echocardiogram. The primary outcome was major adverse cardiac or cerebrovascular event (MACCE), defined as a composite of death from cardiovascular cause, myocardial infarction, stroke, or rehospitalization from cardiovascular cause. Among them, 160 patients showed immediate improvement in LVEF. The independent predictors of immediate LVEF improvement were absence of hypertension and baseline significant aortic regurgitation, and greater baseline LV mass index. Immediate improvement in LVEF was significantly associated with a lower risk of MACCE (adjusted hazard ratio, 0.48; 95% confidence interval, 0.28-0.81; p = 0.01). In conclusion, approximately one-fourth of patients with severe AS who underwent TAVI showed immediate improvement in LVEF during index hospitalization. Immediate LVEF recovery was associated with a lower risk of MACCE during follow-up.

Trial registration: ClinicalTrials.gov NCT03298178.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aortic Valve Insufficiency / epidemiology
  • Aortic Valve Insufficiency / physiopathology
  • Aortic Valve Stenosis / physiopathology
  • Aortic Valve Stenosis / surgery*
  • Cardiovascular Diseases / mortality
  • Female
  • Humans
  • Hypertension / epidemiology
  • Male
  • Myocardial Infarction / epidemiology
  • Patient Readmission / statistics & numerical data
  • Prognosis
  • Proportional Hazards Models
  • Recovery of Function*
  • Stroke / epidemiology
  • Transcatheter Aortic Valve Replacement*
  • Treatment Outcome
  • Ventricular Dysfunction, Left / physiopathology*
  • Ventricular Function, Left

Associated data

  • ClinicalTrials.gov/NCT03298178